Applied DNA Sciences Inc (APDN) financial statements (2020 and earlier)

Company profile

Business Address 50 HEALTH SCIENCES DRIVE
STONY BROOK, NY 11790
State of Incorp. DE
Fiscal Year End September 30
SIC 738 - Miscellaneous Business Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9123471
Cash and cash equivalents9123471
Receivables0113641
Inventory, net of allowances, customer advances and progress billings00000  
Inventory00000  
Prepaid expense     00
Deferred costs    0 0
Other undisclosed current assets11100 (0)
Total current assets:1024611122
Noncurrent Assets
Property, plant and equipment0001111
Long-term investments and receivables    22 
Accounts and financing receivable, after allowance for credit loss    22 
Intangible assets, net (including goodwill)1111220
Goodwill000000 
Intangible assets, net (excluding goodwill)1111220
Deposits noncurrent assets00000  
Deferred costs 0     
Other undisclosed noncurrent assets    000
Total noncurrent assets:1122441
TOTAL ASSETS:1146816164
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1211221
Accounts payable1110211
Accrued liabilities0000000
Employee-related liabilities0000110
Taxes payable 0     
Interest and dividends payable      0
Deferred revenue01
Due to related parties      2
Deferred revenue and credits0201
Other undisclosed current liabilities  2    
Total current liabilities:2231434
Noncurrent Liabilities
Long-term debt and lease obligation112  0 
Long-term debt, excluding current maturities112  0 
Liabilities, other than long-term debt110 1  
Deferred revenue and credits 1  
Accounts payable and accrued liabilities110    
Other undisclosed noncurrent liabilities 0  0 1
Total noncurrent liabilities:222 101
Total liabilities:4451535
Stockholders' equity
Stockholders' equity attributable to parent, including:7(1)171013(1)
Common stock00000  
Additional paid in capital267256249244234224198
Accumulated deficit(259)(257)(248)(237)(224)(212)(200)
Other undisclosed stockholders' equity attributable to parent     00
Stockholders' equity attributable to noncontrolling interest(0)(0)     
Total stockholders' equity:7(1)171013(1)
TOTAL LIABILITIES AND EQUITY:1146816164

Income statement (P&L) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Revenues5545493
Revenue, net5493
Cost of revenue(1)(1)(1)(1)(1)  
Cost of goods and services sold(1)(1)     
Gross profit:4534393
Operating expenses(13)(14)(14)(16)(16)(17)(15)
Operating loss:(9)(9)(12)(13)(12)(8)(12)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(0)(0)0(0)0
Interest and debt expense(1)(1)(0)  (0) 
Loss from continuing operations before equity method investments, income taxes:(10)(10)(12)(13)(12)(8)(12)
Other undisclosed income (loss) from continuing operations before income taxes22(0)00(4)(1)
Loss from continuing operations before income taxes:(8)(9)(12)(13)(12)(12)(13)
Income tax expense (benefit) (0)(4)55(10)(1)
Other undisclosed loss from continuing operations(0)      
Net loss:(8)(9)(15)(8)(7)(22)(14)
Net income attributable to noncontrolling interest00     
Other undisclosed net income (loss) attributable to parent0 4(5)(5)101
Net loss attributable to parent:(8)(9)(12)(13)(12)(12)(13)
Other undisclosed net loss available to common stockholders, basic(0)(0)     
Net loss available to common stockholders, diluted:(8)(9)(12)(13)(12)(12)(13)

Comprehensive Income ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net loss:(8)(9)(15)(8)(7)(22)(14)
Comprehensive loss:(8)(9)(15)(8)(7)(22)(14)
Comprehensive income, net of tax, attributable to noncontrolling interest00     
Other undisclosed comprehensive income, net of tax, attributable to parent0      
Comprehensive loss, net of tax, attributable to parent:(8)(9)(15)(8)(7)(22)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: